Search Results

2155 results were found

Activity Type CME Provider Title Credit Hours Fee End Date
Reset sort order
JAMA Comparative Safety of In Utero Exposure to Buprenorphine Combined With Naloxone vs Buprenorphine Alone 1 Yes 8/12/2027
JAMA Internal Medicine Comparison of Home Antigen Testing With RT-PCR and Viral Culture During the Course of SARS-CoV-2 Infection 1 Yes 5/2/2025
JAMA Network Open Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients 1 Yes 5/31/2025
JAMA Network Open Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, Canada 1 Yes 8/8/2025
JAMA Concordance of SARS-CoV-2 Results in Self-collected Nasal Swabs vs Swabs Collected by Health Care Workers in Children and Adolescents 1 Yes 8/30/2025
American Medical Association Confronting Ageism in Medicine 0.5 Yes 11/26/2027
Oregon Health & Science University School of Medicine Congenital Cardiac Case Conference 30 No 12/31/2025
JAMA Otolaryngology – Head & Neck Surgery Congenital Cutaneous Sinus at the Sternoclavicular Joint 1 Yes 7/25/2027
JAMA Oncology Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB) 1 Yes 4/21/2025
JAMA Oncology Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB) - A Systematic Review and Delphi Consensus Statement 1 Yes 4/21/2025
JAMA Oncology Contemporary Management of Acute Myeloid Leukemia - A Review 1 Yes 8/8/2027
American Medical Association Contracting in Private Practice 0.25 Yes 2/6/2027
Louisiana Medical Mutual Insurance Company (LAMMICO) Controlled Substances Series: Arkansas License Renewals 1.25 Yes 2/9/2027
Louisiana Medical Mutual Insurance Company (LAMMICO) Controlled Substances Series: Best Practices for Prescribing 1.25 Yes 2/9/2027
Louisiana Medical Mutual Insurance Company (LAMMICO) Controlled Substances Series: Drug Diversion Prevention 0.75 Yes 2/9/2027
Louisiana Medical Mutual Insurance Company (LAMMICO) Controlled Substances Series: Fundamentals of Addiction and Addiction Treatment 1.25 Yes 2/9/2027
JAMA Internal Medicine Coronary Artery Lesions at the Same Site Presenting With Different Electrocardiogram Patterns 1 Yes 5/2/2025
JAMA Dermatology Cost and Cost-Effectiveness of the Management Strategies of Chronic Urticaria - A Systematic Review 1 Yes 8/28/2027
JAMA Ophthalmology Cotton Swab Couching of Dislocated Crystalline Lens in Marfan Syndrome 1 Yes 12/19/2027
JAMA Internal Medicine COVID-19 Disease Severity in Persons Infected With Omicron BA.1 and BA.2 Sublineages and Association With Vaccination Status 1 Yes 8/30/2025